Technical Analysis for PTCT - PTC Therapeutics, Inc.
|Grade||Last Price||% Change||Price Change|
PTCT closed up 0.68 percent on Friday, October 20, 2017, on 60 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.
Earnings due: Nov 1
|Weak or Absent||Up||Down||Down|
|See historical PTCT trend table...|
|Date||Alert Name||Type||% Chg|
|Oct 20||NR7||Range Contraction||0.00%|
|Oct 20||Narrow Range Bar||Range Contraction||0.00%|
|Oct 20||Stochastic Reached Oversold||Other||0.00%|
|Oct 18||Doji - Bearish?||Reversal||-2.52%|
|Oct 18||Non-ADX 1,2,3,4 Bearish||Bearish Swing Setup||-2.52%|
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio.
PTC Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of orally administered and proprietary small-molecule drugs for patients living with serious and life-threatening conditions, including genetic and neuromuscular disorders, cancer, and infectious diseases. Its approach includes post-transcriptional control, RNA biology, and gene expression modulation by small-molecules. The company has strategic alliances with AstraZeneca; Celgene Corporation; Cystic Fibrosis Foundation; Genzyme Corporation; Gilead; Muscular Dystrophy Association; Merck & Co., Inc.; Parent Project Muscular Dystrophy; Pfizer Inc.; Roche; Spinal Muscular Atrophy Foundation; and Wellcome Trust. PTC Therapeutics, Inc. was founded in 1998 and is based in South Plainfield, New Jersey.
|Indicator||Bull Case||Neutral / Hold||Bear Case|
|Oversold / Overbought|
|Summary:||Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.|
See more PTCT news...
|52 Week High||22.0|
|52 Week Low||4.03|
|200-Day Moving Average||15.3636|
|50-Day Moving Average||19.1342|
|20-Day Moving Average||18.4515|
|10-Day Moving Average||17.984|
|Average True Range||1.0773|
|Chandelier Exit (Long, 3 ATRs )||18.3481|
|Chandelier Exit (Short, 3 ATRs )||17.7919|
|Upper Bollinger Band||20.4787|
|Lower Bollinger Band||16.4243|
|Percent B (%b)||0.34|
|MACD Signal Line||-0.3687|
|Market Cap||734.8 Million|
|Num Shares||41.3 Million|
|Price-to-Earnings (P/E) Ratio||-5.83|
|Pivot Point Level||Traditional / Classic||Fibonacci||Demark||Woodie||Camarilla|
|Resistance 4 (R4)||18.39|
|Resistance 3 (R3)||18.39||18.19||18.29|
|Resistance 2 (R2)||18.19||18.04||18.19||18.26|
|Resistance 1 (R1)||17.99||17.94||18.09||17.99||18.22|
|Support 1 (S1)||17.59||17.64||17.69||17.59||17.36|
|Support 2 (S2)||17.39||17.54||17.39||17.32|
|Support 3 (S3)||17.19||17.39||17.29|
|Support 4 (S4)||17.19|